Weighted descriptive statistics, design-based F-tests, t-tests, and linear regression were used to assess associations between GLP-1 use and BMI, adjusting for demographics, insurance, cardiovascular disease, and year. The gene discussed is GLP1R; the disease is cardiovascular disorder.